launch
Madrigal’s MASH Drug Rezdiffra Surpasses Q2 Sales Estimates
Madrigal Pharmaceuticals, Rezdiffra, MASH drug, Q2 earnings, sales estimates, FDA approval, commercial launch, NASH treatment
RNA Startup ReNAgade Acquired by Competitor Following Mega-Round Funding
ReNAgade, RNA, startup, acquisition, competitor, mega-round funding, launch
Verona Pharma Prepares $650 Million Funding Pool for Ensifentrine Launch Ahead of FDA Decision
Verona Pharma, COPD, Ensifentrine, FDA, funding pool, launch, clinical trials, chronic obstructive pulmonary disease
2 former Apple Tree investors roll toward new biotech-focused fund launching with $310M
Scion, launch, Scion Life Sciences